文献速递药物相互作用药物不良反应与药物警戒

低剂量大麻二酚升高阿米替林血浆浓度:一项临床药物相互作用研究

Low-dose cannabidiol increases plasma concentrations of amitriptyline: A clinical drug-drug interaction study.
PubMed 文献 · Br J Clin Pharmacol · 2025-12-15

本研究在13名健康受试者中开展开放标签、固定序列、两周期交叉试验,评估单次30 mg大麻二酚(CBD)对阿米替林和曲马多药代动力学的影响。结果显示CBD显著升高阿米替林的AUC0-24h和Cmax,但未显著改变去甲替林、曲马多及O-去甲基曲马多的暴露。

要点

  • 单次30 mg CBD显著升高阿米替林AUC0-24h(比值1.13)和Cmax(比值1.17)。
  • CBD未显著改变去甲替林、曲马多及O-去甲基曲马多的药代动力学参数。
  • 长期用药和餐食状态可能使CBD相关相互作用更明显。

核心结论

  • 单次30 mg CBD显著影响健康志愿者体内阿米替林的代谢,升高其血浆暴露。

研究设计与样本

  • 第1天空腹口服阿米替林25 mg和曲马多50 mg,洗脱7天后第8天提前1小时口服CBD 30 mg后再给药。
  • 采样至给药后24小时,采用混合效应模型比较AUC。

主要发现

  • CBD使阿米替林AUC0-24h的LSM比值为1.13(95%CI 1.01–1.26,p=0.033)。
  • CBD使阿米替林Cmax的LSM比值为1.17(95%CI 1.01–1.36,p=0.041)。
  • 去甲替林、曲马多AUC0-24h和Cmax及O-去甲基曲马多Cmax无显著变化。

临床怎么用

  • 临床合用CBD与阿米替林时应关注阿米替林暴露升高及其相关不良反应风险。
  • 长期CBD用药或餐后状态可能使相互作用更明显,需个体化评估。

局限性

  • 开放标签、固定序列设计可能引入偏倚。
  • 结论基于健康志愿者,患者中长期用药和餐食影响未直接验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Cannabidiol (CBD), the main non-intoxicating compound from the cannabis plant, is regularly used by patients with chronic pain who also take analgesics. CBD has previously been shown to inhibit CYP-mediated drug metabolism. This study aimed to characterize the potential pharmacokinetic interaction of CBD with amitriptyline and tramadol, two commonly used analgesics. METHODS: This was an open-label, fixed-sequence, 2-way crossover study in 13 healthy participants. On Day 1, 25 mg amitriptyline and 50 mg tramadol were co-administered orally in a fasted condition, followed by a 7-day washout period. On Day 8, 30 mg CBD was administered orally 1 h prior to amitriptyline and tramadol. Pharmacokinetic sampling was performed for CBD, amitriptyline, tramadol and their respective active metabolites nortriptyline and O-desmethyltramadol for up to 24 h post-dose. The areas under the curve (AUCs) were compared between visits using a mixed effects model. RESULTS: Twelve participants (4M/8F) completed the study; one participant (M) dropped out for personal reasons. CBD significantly increased the AUC0-24h (least square means [LSM] ratio 1.13, 95% CI: 1.01, 1.26, p = 0.033) and the Cmax (LSM ratio 1.17, 95% CI: 1.01, 1.36, p = 0.041) of amitriptyline. CBD did not significantly change the AUC0-24h and Cmax of nortriptyline and tramadol, and the Cmax of O-desmethyltramadol. CONCLUSIONS: A single dose of 30 mg CBD significantly influenced the metabolism of amitriptyline in healthy volunteers. In patients, CBD-induced drug interactions may be more pronounced in chronic dosing and dependent upon prandial status.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Gorbenko AA, Post TE, Strugala PK, et al. Low-dose cannabidiol increases plasma concentrations of amitriptyline: A clinical drug-drug interaction study. Br J Clin Pharmacol. 2025. PMID: 41398552. doi:10.1002/bcp.70415

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。